mHealth Summit
December 3-5, 2012
The Gaylord National Resort and Convention Center
Washington, DC
Register
What Goes Into Making an Extraordinary mHeath App?
As a part of the mHealth Summit Technology Trends track, on Wednesday, December 5 from 11:30 AM - 12:45 PM, Involution Studios Creative Director Juhan Sonin will join a distinguished panel including David Lee Scher, Senior Medical Advisor at Happtique; Anne Giles Clelland, President, CEO and Founder of Handshake Media; Barbara Spanton, Senior UX Designer at Macadamian; and David Windhausen, Senior Vice President of Intouch Solutions to discuss, "What Goes Into Making an Extraordinary mHealth App?".
Technology provides meaningful clinical tools through new mobile devices, apps, sensors, 24/7 monitoring and the cloud. All the innovation that we currently have access to, coupled with the impending data deluge, filtering and analytics are driving transformation across mHealth and the greater healthcare delivery landscape. In this emerging environment, mobile health and medical applications are expected to be big business. What makes an app successful, and what are industry best practices? This session will discuss design elements including: usability, certification, marketing, and collaboration across the ecosystem.
About the mHealth Summit
Now in its fourth year, the mHealth Summit is the largest event of its kind, bringing together leaders in government, the private sector, industry, academia, providers and not-for-profit organizations to advance collaboration in the use of wireless technology to improve health outcomes in the United States and abroad.
The mHealth Summit offers an all-star lineup of visionary keynote speakers and conference tracks. Conference sessions will explore, examine, and debate the ways mobile technology is transforming health care delivery, research, business and policy for the 21st century both in the U.S. and internationally. The summit also focuses on mHealth research, facilitating the development and commercialization of empirically-supported solutions for specific disease states.